Details of the Drug
General Information of Drug (ID: DMNRHSO)
Drug Name |
BENZYLIMIDAZOLE
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1-Benzylimidazole; 1-Benzyl-1H-imidazole; 4238-71-5; N-Benzylimidazole; Imidazole, 1-benzyl-; BENZYLIMIDAZOLE; 1H-Imidazole, 1-(phenylmethyl)-; 1-BENZYL IMIDAZOLE; CCRIS 5821; EINECS 224-200-4; 1-Benzylimidazole, 99%; NSC 217337; NSC 126828; CHEMBL14192; AI3-52572; MLS000069473; KKKDZZRICRFGSD-UHFFFAOYSA-N; MFCD00005296; SMR000059044; 1BN; 1-benzylimdazole; 2afx; 1-benzyl-imidazole; 3pb9; 1-Benzylimidazole (BI); Maybridge3_003880; Opera_ID_1637; SCHEMBL414; ACMC-209jp9; AC1Q28WR; AC1L2U3N; AC1Q4X5Z; AC1Q28WS; KSC492M7H; MLS001424205
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 158.2 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||